Daratumumab in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Cancer Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN
Blood Cancer J 2024 Jul 08;14(1)107, A Chari, JL Kaufman, J Laubach, DW Sborov, B Reeves, C Rodriguez, R Silbermann, LJ Costa, LD Anderson, N Nathwani, N Shah, N Bumma, SA Holstein, C Costello, A Jakubowiak, TM Wildes, RZ Orlowski, KH Shain, AJ Cowan, H Pei, A Cortoos, S Patel, TS Lin, PM Voorhees, SZ Usmani, PG RichardsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.